The present invention relates to polymorphic crystalline forms or a non-crystalline form or amorphous of the compound (3-(((4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino)-methyl)-phenoxy)-acetic acid sodium salt or a hydrate thereof together with processes for preparing, methods for using, and pharmaceutical compositions containing the same. The invention also relates to substantially pure polymorphic crystalline forms or a non-crystalline form or amorphous form of (3-(((4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino)-methyl)-phenoxy)-acetic acid sodium salt or a hydrate thereof.
本发明涉及化合物(3-(((4-
叔丁基苯基)-(
吡啶-3-磺酰基)-
氨基)-甲基)-苯氧基
乙酸钠盐或其
水合物的多形晶体形式或非晶态形式,以及制备方法、使用方法和含有该化合物的制药组合物。该发明还涉及(3-(((4-
叔丁基苯基)-(
吡啶-3-磺酰基)-
氨基)-甲基)-苯氧基
乙酸钠盐或其
水合物的)基本纯的多形晶体形式或非晶态形式。